|
2025
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of oncological related diseases and ... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of oncological related diseases and... |
|
2024
|
Invention
|
Epha2 antibodies.
Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferential... |
|
|
Invention
|
Anti-tumor antibodies. Provided herein are antibodies that target tumors. These antibodies bind p... |
|
|
Invention
|
Immunoconjugates and methods.
Immunoconjugates of the Formula (I) include a linking group for li... |
|
|
Invention
|
Immunoconjugates and methods. n (I)
|
|
|
Invention
|
Combination of immunotherapeutics and bisfluoroalkyl-1,4-benzodiazepinone compounds for treating ... |
|
2023
|
Invention
|
Antibody cocktail against sars-cov-2 spike protein.
Provided herein are antibodies that are usef... |
|
|
Invention
|
Combination anti-epn1 and anti-pd-l1 antibody therapies. This invention relates to treating cance... |
|
2022
|
Invention
|
Immunoconjugates and methods. n (I)
|
|
|
Invention
|
Immunoconjugates and methods. Immunoconjugates of the Formula (I) include a linking group for lin... |
|
|
Invention
|
Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating cancer.
The p... |
|
|
Invention
|
Methods of administering antibodies against sars-cov-2 spike protein. Provided herein are methods... |
|
|
Invention
|
Il-38-specific antibodies.
This invention relates to antibodies specific for human interleukin-3... |
|
|
Invention
|
Il-38-specific antibodies. This invention relates to antibodies specific for human interleukin-38... |
|
|
Invention
|
Epha2 antibodies. Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferentiall... |
|
|
Invention
|
Antibody cocktail against sars-cov-2 spike protein. Provided herein are antibodies that are usefu... |
|
2021
|
Invention
|
Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating adenoid cystic... |
|
|
Invention
|
Snx9 subfamily-targeting antibodies. This invention relates to antibodies specific for members of... |
|
|
Invention
|
Methods of preparing chiral benzodiazepinone derivatives.
The present invention provides methods... |
|
2020
|
Invention
|
Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof. The present invention p... |
|
|
Invention
|
Il-38-specific antiobodies. This invention relates to antibodies specific for human interleukin-3... |
|
|
Invention
|
Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating notch-activated breast cancer.
The pr... |
|
2019
|
Invention
|
Exosome-targeting bispecific antibodies.
The inventions described herein are directed to bispeci... |
|
|
Invention
|
Exosome-targeting bispecific antibodies. The inventions described herein are directed to bispecif... |
|
|
Invention
|
Antibodies targeting epn1.
Described herein, are antibodies specific for epsin-1 (EPN1), an anti... |
|
|
Invention
|
Antibodies targeting epn1. Described herein, are antibodies specific for epsin-1 (EPN1), an antig... |
|
|
Invention
|
Ch3 domain epitope tags.
This invention relates to the incorporation of one, or more, heterologo... |
|
|
Invention
|
Ch3 domain epitope tags. This invention relates to the incorporation of one, or more, heterologou... |
|
|
Invention
|
Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof.... |
|
|
Invention
|
Compositions comprising cd20 inhibitors and bisfluoroalkyl-1,4-benzodiazepinone compounds and met... |
|
|
Invention
|
Combination compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of ... |
|
|
G/S
|
Monoclonal antibodies for medical and scientific research; antibodies and immunoconjugates for me... |
|
2016
|
G/S
|
Biotechnology services, namely, development of monoclonal antibodies; pharmaceutical, medical, sc... |
